Aytu BioPharma to Present at Upcoming June Investor Conferences saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.
Acerus Reports First Quarter 2021 Financial Results
Nachrichtenquelle: globenewswire | 13.05.2021, 13:30 | 54 | 0 TORONTO, May 13, 2021 (GLOBE NEWSWIRE) Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three-month period ended March 31, 2021. Unless otherwise noted, all amounts are in US dollars and are prepared in accordance with International Financial Reporting Standards (“IFRS”).
Q1 - 2021 Highlights
Re-purchased all remaining NATESTO rights from Aytu Biopharma, allowing Acerus to build and leverage its commercial business across North America
Expanded NATESTO access to 20 countries across Europe, Central Asia and the Middle East through an agreement with Maylen Farma (“Maylen”), a firm
SEATTLE, May 04, 2021, (PHARMIWEB) Worldwide Androgen Replacement Therapy Market, By Product Type (Creams/Gels, Patches, Injections, Implants, and Oral Tablets/Capsules/Gums), By Active Ingredient Type (Testosterone, Methyl Testosterone, Testosterone Undecanoate, Testosterone Enanthate, and Testosterone Cypionate),.
Aytu BioScience Announces Close of Merger with Neos Therapeutics saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.
Aytu BioScience Announces Close of Merger with Neos Therapeutics newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.